Switch theme
Sign up to access all valuation multiples
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
1985
7.1K+
LTM Revenue $4.1B
LTM EBITDA $1.3B
$13.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Hologic has a last 12-month revenue of $4.1B and a last 12-month EBITDA of $1.3B.
In the most recent fiscal year, Hologic achieved revenue of $4.0B and an EBITDA of $1.3B.
Hologic expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Hologic valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $4.0B | $4.0B | XXX | XXX | XXX |
| Gross Profit | $3.0B | $2.1B | XXX | XXX | XXX |
| Gross Margin | 74% | 51% | XXX | XXX | XXX |
| EBITDA | $1.1B | $1.3B | XXX | XXX | XXX |
| EBITDA Margin | 28% | 32% | XXX | XXX | XXX |
| Net Profit | $1.3B | $456M | XXX | XXX | XXX |
| Net Margin | 32% | 11% | XXX | XXX | XXX |
| Net Debt | $484M | $95.7M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Hologic's stock price is $59.
Hologic has current market cap of $13.2B, and EV of $13.8B.
See Hologic trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13.8B | $13.2B | XXX | XXX | XXX | XXX | $4.18 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Hologic has market cap of $13.2B and EV of $13.8B.
Hologic's trades at 3.4x LTM EV/Revenue multiple, and 10.3x LTM EBITDA.
Analysts estimate Hologic's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Hologic and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $13.8B | XXX | XXX | XXX |
| EV/Revenue | 3.4x | XXX | XXX | XXX |
| EV/EBITDA | 10.5x | XXX | XXX | XXX |
| P/E | 15.8x | XXX | XXX | XXX |
| P/E/Growth | 1.2x | XXX | XXX | XXX |
| EV/FCF | 12.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpHologic's NTM/LTM revenue growth is 3%
Hologic's revenue per employee for the last fiscal year averaged $0.6M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Hologic's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Hologic's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Hologic and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 0% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 32% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 17% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 36% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.6M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 15% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 7% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 32% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Hologic acquired XXX companies to date.
Last acquisition by Hologic was XXXXXXXX, XXXXX XXXXX XXXXXX . Hologic acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Hologic founded? | Hologic was founded in 1985. |
| Where is Hologic headquartered? | Hologic is headquartered in United States of America. |
| How many employees does Hologic have? | As of today, Hologic has 7.1K+ employees. |
| Who is the CEO of Hologic? | Hologic's CEO is Mr. Stephen P. Macmillan. |
| Is Hologic publicy listed? | Yes, Hologic is a public company listed on NAS. |
| What is the stock symbol of Hologic? | Hologic trades under HOLX ticker. |
| When did Hologic go public? | Hologic went public in 1990. |
| Who are competitors of Hologic? | Similar companies to Hologic include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Hologic? | Hologic's current market cap is $13.2B |
| What is the current revenue of Hologic? | Hologic's last 12-month revenue is $4.1B. |
| What is the current EBITDA of Hologic? | Hologic's last 12-month EBITDA is $1.3B. |
| What is the current EV/Revenue multiple of Hologic? | Current revenue multiple of Hologic is 3.4x. |
| What is the current EV/EBITDA multiple of Hologic? | Current EBITDA multiple of Hologic is 10.3x. |
| What is the current revenue growth of Hologic? | Hologic revenue growth between 2023 and 2024 was 0%. |
| Is Hologic profitable? | Yes, Hologic is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
